News
The new plans are in addition to $21B that the drug manufacturer has already committed to U.S. research, development and ...
Gilead Sciences announced $11 billion in new planned investment in the U.S. to add to its domestic manufacturing and research ...
Gilead Sciences said Wednesday it will invest $11 billion in U.S. research and manufacturing in the coming years, joining ...
Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...
Shares of Gilead Sciences Inc. GILD shed 1.27% to $96.91 Friday, on what proved to be an all-around dismal trading session ...
Gilead’s Livdelzi Shows Lasting Efficacy in Primary Biliary Cholangitis, Regardless of Prior Therapy
Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...
Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump ...
The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...
Gilead will construct three new facilities in the U.S., while upgrading three others. The company claims the investment will ...
Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
T Fagbenle and co-showrunner Yahlin Chang, talk to The Hollywood Reporter about June's eye-opening revelation amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results